Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
about
RAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disordersStructural studies of CNG repeatsMouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Twisting right to left: A…A mismatch in a CAG trinucleotide repeat overexpansion provokes left-handed Z-DNA conformationA dynamic structural model of expanded RNA CAG repeats: a refined X-ray structure and computational investigations using molecular dynamics and umbrella sampling simulations.RNA phase transitions in repeat expansion disorders.Trinucleotide repeats: a structural perspective'Costa da Morte' ataxia is spinocerebellar ataxia 36: clinical and genetic characterization.Examining the interactions of the splicing factor MBNL1 with target RNA sequences via a label-free, multiplex methodTargeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects.Oligonucleotide-based strategies to combat polyglutamine diseases.An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseasesRNA-protein interactions in unstable microsatellite diseases.MBNL proteins and their target RNAs, interaction and splicing regulation.Barnacle: detecting and characterizing tandem duplications and fusions in transcriptome assembliesEffects on murine behavior and lifespan of selectively decreasing expression of mutant huntingtin allele by supt4h knockdownThe role of the immune system in triplet repeat expansion diseasesHuntingtin Exists as Multiple Splice Forms in Human Brain.RNA-binding protein misregulation in microsatellite expansion disordersRNA Structures as Mediators of Neurological Diseases and as Drug Targets.Nuclear retention of full-length HTT RNA is mediated by splicing factors MBNL1 and U2AF65On the Applicability of Elastic Network Models for the Study of RNA CUG Trinucleotide Repeat Overexpansion.Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type IRNA imaging in living cells - methods and applications.Cooperation meets competition in microRNA-mediated DMPK transcript regulation.Allele-selective inhibition of trinucleotide repeat genes.Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathwayThe first crystal structures of RNA-PNA duplexes and a PNA-PNA duplex containing mismatches--toward anti-sense therapy against TREDsRNA interference targeting CUG repeats in a mouse model of myotonic dystrophy.Structural characterization of a dimer of RNA duplexes composed of 8-bromoguanosine modified CGG trinucleotide repeats: a novel architecture of RNA quadruplexesA low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle.RNA toxicity in polyglutamine disorders: concepts, models, and progress of researchss-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategy.Treatment of type 1 myotonic dystrophy by engineering site-specific RNA endonucleases that target (CUG)(n) repeats.RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity.Pre-mRNA splicing in disease and therapeutics.Treatment implications of C9ORF72.Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunctionSmall non-coding RNAs add complexity to the RNA pathogenic mechanisms in trinucleotide repeat expansion diseases.
P2860
Q26823908-4D71AD67-418D-421D-8B94-8565D5FD8A13Q26851232-23F9C92A-E300-43E0-999E-CF9AB08049B1Q27005950-32519391-3113-4D89-86BA-E99A2C8E0B9DQ27319575-1AAC4D0A-9F2D-479C-857B-8B15483440ACQ27676633-0DAB28F9-51F9-41E5-BA7B-E682FC7A7630Q30224330-8FF81EEA-10D0-4292-9546-42C161D87F80Q30432441-30411EC0-ACE0-4B58-863D-EB209283BC6DQ30468222-994D8124-2A9E-4476-8976-0ABC3350B756Q30572364-8C2FBD30-3688-4CCD-AAB5-86E34BF3A8CFQ33588831-CA0A15D7-3510-4FB9-B488-25A94DF68B2DQ33698593-94BD5FEB-0990-4DD5-815E-C0942329DFCDQ33791247-5DE6958A-94D3-4475-A739-87605167013DQ34187525-435B88CB-1A53-46A1-ADE7-92F1380C276EQ34243144-80099742-B48D-47A8-9ABC-4C641C655207Q34248811-FB4554CE-3921-4A2A-A9F0-514B1371B44DQ34939070-A4AC05B2-BF97-4EFD-B580-7538A1F445A5Q35168414-E157C2FA-B939-438A-8953-C19782AE1FCEQ35271805-66E18CEE-3A1B-4276-AA91-C01E82A0E62BQ35784831-351E60C6-4BFD-4796-995C-4C6AA418CE7BQ35789502-10E8A52E-6CCB-409C-90FA-70D8C9908340Q35868044-09CE14B6-8A88-4E08-9AAC-67D38830EC45Q35896064-A3794E01-A7DB-443D-A910-4D176A20070CQ35968544-88AD6090-EBF4-4A89-8A83-3F9175BB85C4Q36051366-E0C01B07-5093-4D51-AD9D-42DFAA3FD9A9Q36189974-B6E245B9-5E26-4143-8DC3-4C0647DB17C9Q36228044-17079979-2601-4286-9518-D498F763BEBDQ36310758-767BA47A-8307-4FA5-BADE-BA8CC7119D05Q36477988-1401635D-72C8-485C-B1BB-93047E68B40BQ36627956-2C8D8C2D-183D-4A46-894A-9931FAAF996FQ36673701-62FD8BF9-5DB1-458B-AF50-B2C2583A69DCQ36701084-4E03F5E7-968F-48EB-9A06-5D41A7DD4C6AQ36722690-6C4C65BF-43BA-4DA6-A0C1-BD81040D1F63Q36859984-421791FF-C053-46EF-9DD8-C6FEEBF63DBEQ37271206-18138744-4DD8-47C5-8587-65E6C8B6F872Q37562085-3B5E3142-119B-4E3D-83AE-D10A1F8D3BB3Q37992334-149BB749-CFC1-49C2-B05E-847BC6BD1EB5Q38028093-4CE4DE27-202B-47AA-8012-F4BE1A7D30B5Q38062966-BA475900-3504-4B1C-A0B7-158014113D21Q38122142-6C9D8066-65B5-4831-A2CD-57534F1CEEEDQ38172118-43EA3B86-C565-46DB-A4B4-7A30C3BA1BE8
P2860
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
@ast
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
@en
type
label
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
@ast
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
@en
prefLabel
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
@ast
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
@en
P2093
P2860
P356
P1476
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
@en
P2093
Agnieszka Mykowska
Krzysztof Sobczak
Marzena Wojciechowska
Piotr Kozlowski
P2860
P356
10.1093/NAR/GKR729
P407
P577
2011-09-09T00:00:00Z
2012-01-01T00:00:00Z